- Previous Close
2,110.00 - Open
2,110.00 - Bid 1,960.00 x --
- Ask 2,213.00 x --
- Day's Range
1,969.00 - 2,218.00 - 52 Week Range
1,870.00 - 3,010.00 - Volume
3,000 - Avg. Volume
4,108 - Market Cap (intraday)
2.895B - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
9.31 - EPS (TTM)
238.00 - Earnings Date Feb 6, 2025
- Forward Dividend & Yield 140.00 (6.32%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Sugai Chemical Industry Co., Ltd. manufactures and sells various chemicals in Japan. The company offers pharmaceutical intermediates that are used in manufacturing circulatory systems, respiratory systems, antimicrobial and antiviral, cancer, and central nervous system agents; and active ingredients and intermediates, such as fungicides, insecticides, herbicides, and veterinary pharmaceuticals. It also provides functional chemicals that are used in manufacturing of optical and electronic materials, resins and monomers, cosmetics, and fragrances; dye and pigment intermediaries; and surfactants. The company was formerly known as Sugai Chemical Factory and changed its name to Sugai Chemical Industry Co., Ltd. in 1952. Sugai Chemical Industry Co., Ltd. was founded in 1928 and is headquartered in Wakayama, Japan.
www.sugai-chem.co.jp182
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 4120.T
View MorePerformance Overview: 4120.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4120.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4120.T
View MoreValuation Measures
Market Cap
2.89B
Enterprise Value
3.17B
Trailing P/E
9.31
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.44
Price/Book (mrq)
0.40
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
4.62
Financial Highlights
Profitability and Income Statement
Profit Margin
5.68%
Return on Assets (ttm)
2.30%
Return on Equity (ttm)
4.99%
Revenue (ttm)
6.45B
Net Income Avi to Common (ttm)
366M
Diluted EPS (ttm)
238.00
Balance Sheet and Cash Flow
Total Cash (mrq)
417M
Total Debt/Equity (mrq)
20.77%
Levered Free Cash Flow (ttm)
--